Recent Headlines
Within Biotechnology
BioPharm Systems to Host Webinar on Sharing CTMS Data Between Sponsors and CROs
Leading provider of Oracle's clinical trial, data, safety, and pharmacovigilance systems will discuss the trend of outsourcing clinical trial management, as well as the various approaches to sharing CTMS data between sponsors and CROs. - May 18, 2012 - BioPharm Systems
IonSense Presenting OpenSpot Mass Spectrometry™ at the American Society for Mass Spectrometry Annual Conference
OpenSpot™ Sample Cards Facilitate Simpler Analysis, Eliminating Most Consumables and Solvents, Reducing Costs and Lab Waste. Exhibited at ASMS 2012. Booth #57. - May 17, 2012 - IonSense, Inc.
Colorado BioScience Association Applauds Organizers of the Third Annual Gold Lab Symposium at the University of Colorado
Colorado BioScience Association (CBSA) applauds Dr. Larry Gold and his team at the University of Colorado for their efforts in organizing the third annual Gold Lab Symposium. The annual two-day educational event brings together ground-breaking thought leaders to discuss biological innovations and the improvement of health care. - May 16, 2012 - Colorado BioScience Association
AnaSpec Offers PEGylated Peptides Synthesis
PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple modification of a drug with polyethylene glycol (PEG) not only is capable of improving the drug’s solubility, diminishing the potential for aggregation, and... - May 16, 2012 - AnaSpec, EGT Group
Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry
Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc
Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium
Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc
Eppendorf to Support BioNexus Companies in Malaysia
Eppendorf Asia Pacific Sdn Bhd has announced its support for biotechnology companies that have been granted BioNexus status in Malaysia. The support will be in the form of additional benefits to top up the fiscal incentives, grants and guarantees endowed by their BioNexus status. Specifically, any... - May 10, 2012 - Eppendorf Asia Pacific Sdn Bhd
Stevens Team Wins First Place in New Jersey ISPE Student Poster Competition
Diagnostic invention allows clinicians to comprehensively evaluate spinal movement - May 10, 2012 - Stevens Institute of Technology
Explosive Detection Research to be Presented at ASMS Conference
Stevens student awarded travel grant to present research in Vancouver - May 10, 2012 - Stevens Institute of Technology
Virginia Women’s Center Makes Generous Donation and Commitment in Hanover County
Richmond-based women’s health practice rallies its physicians and staff to build a house on the 1.8 acres of land the practice has donated to Hanover Habitat for Humanity in response to housing needs. - May 10, 2012 - Virginia Women's Center
Red Cedar Technology Welcomes New Director of Business Development
Red Cedar Technology announced today that Joe Feord has joined the company as Director of Business Development. In this role, he will be responsible for expanding the company’s presence in the aerospace and defense industries in North America. Joe has 26 years of business experience in... - May 10, 2012 - Red Cedar Technology
Mitegen Announces Consolidation and Improvements to MicroLoops™ Product Lines
MicroLoops™ and MicroLoops™ HT product lines merged and improved with Dual thickness technology, providing an economical option in premium crystal mounts. - May 09, 2012 - MiTeGen, LLC
Stevens Institute of Technology Taps M-Files ECM and Part 11 Compliance Package for their Pharmaceutical Curriculum
University Integrates M-Files into Advanced Validation Course for Pharmaceutical Students - May 09, 2012 - Stevens Institute of Technology
AnaSpec Highlights SensoLyte® 520 Renin Assays for Human, Mouse & Rat Specific
AnaSpec, EGT Group, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit also provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using proprietary 5-FAM/QXL™ 520 fluorescence... - May 09, 2012 - AnaSpec, EGT Group
Technology Developed at Stevens Monitors Available Seating
Seatfinder monitors seating remotely so patrons can check for availability before they leave home. - May 06, 2012 - Stevens Institute of Technology
Avomeen Analytical Services Opens Newly Renovated Pharmaceutical Research and Development Laboratory
Avomeen Analytical Services, an Ann Arbor, Michigan based independent testing laboratory has announced opening of newly renovated pharmaceutical research and development laboratories at its location at 6107 Jackson Rd Ann Arbor, Michigan. Avomeen’s pharmaceutical services include method... - May 05, 2012 - Avomeen Analytical Services
Dr. Glenn Atlas, Stevens Students, and MICRO Stamping Corp. Develop Innovative Medical Technology
V-Scope is a new medical device to help doctors position a breathing tube - May 03, 2012 - Stevens Institute of Technology
OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite
State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
ImmunoReagents Announces Exclusive German Distribution Channel with BioLeague
ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Bioleague as its new distributor in Germany. ImmunoReagents and Bioleague will work together to bring top quality antibodies to the... - April 29, 2012 - ImmunoReagents Inc.
New Research: HidroxⓇ Inhibits E. coli and Reduces Neuroinflammation
While nutraceuticals and dietary supplements are coming under increasing regulatory scrutiny, both in the United States and Europe, for what is perceived to be a lack of verifiable scientific research supporting their claim to beneficial health effects, CreagriⓇ Inc., and HidroxⓇ--its patented formulation of olive polyphenols rich in the potent antioxidant Hydroxytyrosol - continue to achieve new scientific advancements on the road to producing healthy consumer goods. - April 28, 2012 - Creagri, Inc.
Genome Designs Partners with SciDM Group, Securing High Performance Bioinformatics Tools for Internal Pipelines and Custom Projects
Genome Designs, Inc., custom genome annotation and metabolic modeling service provider, today announced a partnership with SciDM Group, a bioinformatics tools developer. Genome Designs will be using SciDM Group’s high performance database engine, transcriptomics data processing pipeline, and... - April 27, 2012 - Genome Designs
Carotech to Share Latest Breakthrough in Tocomin SupraBio Research at SupplySide MarketPlace, New York
They will be sharing with customers and visitors the latest clinical data of their patented and bioenhanced natural full spectrum palm tocotrienol complex. - April 27, 2012 - Carotech Inc.
Bioo Scientific Introduces Optimized Directional RNA-Seq Kits with Innovative Bias Reducing Technology
Bioo Scientific’s patent pending NEXTflex™ Directional RNA-Seq Kits and Barcodes Primer Sets provide an easy, flexible and non-biased solution for generating directional libraries. - April 26, 2012 - Bioo Scientific
HEEDS MDO Optimization with VI-Motorsport Simulation Produces Early Success for Triple Eight Racing Team
MG KX Momentum car wins during first weekend of British Touring Car Championship - April 26, 2012 - Red Cedar Technology
Bioo Scientific Launches Transduction Reagents for Targeted Delivery Into Neuronal and Myeloid Cells
Bioo Scientific’s proprietary MyeloAim™ and NeuroAim™ Transduction Reagents offer targeted delivery of RNAi agents into myeloid and neuronal cells. - April 26, 2012 - Bioo Scientific
Stevens Students Compete in 5th International Roboboat Competition
Unmanned vessel innovations help to advance next-generation naval vessels - April 25, 2012 - Stevens Institute of Technology
Colorado BioScience Association Seeks Region’s Top Start-up Companies for Venture Showcase Competition at BioWest 2012
Colorado BioScience Association (CBSA) is now accepting applications from emerging bioscience companies for the Venture Showcase Competition at BioWest 2012. The deadline for entry is Friday, May 11th. Venture Showcase sponsors include Dorsey & Whitney LLP, EKS&H - Ehrhardt Keefe Steiner & Hottman PC, and the Metro Denver Economic Development Corporation. - April 25, 2012 - Colorado BioScience Association
AnaSpec Introduces Pancreatic β-Cells Specific Antibodies - Anti-hFXYD2γa
AnaSpec, EGT Group is pleased to announce the release of three antibodies (two monoclonal and one polyclonal) against FXYD2γa. FXYD2γa is a regulating subunit of the NA+-K+-ATPase and has been identified as a unique and specific pancreatic beta cell surface biomarker. In individuals... - April 19, 2012 - AnaSpec, EGT Group
BioPharm Systems to Present at Oracle's 7th Annual Health Sciences Innovation Forum
BioPharm Systems, a leading provider of clinical trial, data, and drug safety solutions, and a Gold level member of Oracle PartnerNetwork (OPN), today announced that Parambir Singh, vice president of clinical trial management solutions, and Dr. Rodney Lemery, vice president of safety and... - April 18, 2012 - BioPharm Systems
EinNel Technologies Will Distribute Red Cedar Technology Software in India
Red Cedar Technology announced today that EinNel Technologies has agreed to distribute the HEEDS family of design optimization software throughout India. Albert George of EinNel Technologies said, “Having surveyed the Indian market from the perspective of technology in use, we find that... - April 18, 2012 - Red Cedar Technology
Dr. Yong Shi Awarded Patent for Innovative Control of Piezoelectric Nanofibers
Emerging nanofiber technology establishes tiny, self-powering sensors and actuators with compelling commercial applications. - April 14, 2012 - Stevens Institute of Technology
RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc
Dr. Simon Podkolzin’s International Green Chemistry Collaboration Wins NSF Grant
Nanoparticle catalysts for industrial chemical reactions use oxygen with only water as a byproduct. - April 12, 2012 - Stevens Institute of Technology
Colorado BioScience Association Appoints Four Industry Leaders to Board of Directors
Four industry executives were named to the Colorado BioScience Association (CBSA) Board of Directors at its 2012 Annual All-Member Meeting. New CBSA director appointments include James Chomas, Ph.D., Founder & CEO, Surefire Medical; Scott Deeter, President & CEO, Ventria Bioscience; Brent Fassett, Partner, Cooley LLP; and Kerry Ingalls, Vice President of Colorado Operations, Amgen. - April 05, 2012 - Colorado BioScience Association
BioPharm Systems to Host Webinar on How to Personalize the Siebel Clinical User Interface
Leading provider of clinical trial, data and drug safety solutions will discuss the various ways one can personalize their Siebel Clinical Trial Management System (CTMS) user interface. - April 05, 2012 - BioPharm Systems
Dr. EH Yang's Research Team Awarded with NSF Grant on Pioneering Microfluidics Innovation
Digital microfluidics creates a lab-on-a-chip, enabling portable at-home medical tests. - April 04, 2012 - Stevens Institute of Technology
U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer Product Portfolio
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has been granted U.S. Patent 8,088,385 B2 titled “PFKFB3 inhibitor for the treatment of a Proliferative Cancer” by the United States Patent... - April 04, 2012 - Advanced Cancer Therapeutics
ImmunoReagents Announces Exclusive Japanese Distribution Channel with Funakoshi Ltd. Co.
ImmunoReagents, a manufacturer of high quality secondary antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Funakoshi as its new distributor for Japan. ImmunoReagents and Funakoshi will work closely together to bring top quality antibodies... - March 31, 2012 - ImmunoReagents Inc.
AnaSpec Highlights HiLyte Fluor™ Dyes Collection for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - March 29, 2012 - AnaSpec, EGT Group
NovaTeinBio Announces Discount on New Human PEG 20000 ELISA Kit
Boston-based biological reagents provider NovaTeinBio has recently announced that they’re offering a 10% discount on their new Human PEG 20000 ELISA kit. This discount is designed to help medical researchers across the company to consolidate the cost of their testing in order to refocus their... - March 28, 2012 - Novatein Biosciences
The Jon Block Group Initiates First Tennis Sponsorship with David Konstantinov
Expanding upon the firm’s tremendously successful sponsorship program in motorcycle road racing, The Jon Block Group is pleased to announce its first tennis sponsorship with an endorsement of 17 year old San Francisco native, David Konstantinov. As succinctly put by Kurt Burgess, the... - March 27, 2012 - Jon Block Group
BioPharm Systems Launches Accel-Account Manager for Creating and Managing Oracle Clinical, RDC and TMS User Accounts
Accel-Account Manager allows life sciences companies to easily and cost-effectively manage user accounts without technical knowledge. - March 25, 2012 - BioPharm Systems
Dr. Henry Du Elected SPIE Fellow
Professor Du's interdisciplinary fiber-optic sensing research advances applications in environmental monitoring, medical diagnosis and energy production - March 25, 2012 - Stevens Institute of Technology
Carotech to Showcase Natural Palm Mixed Carotene (Caromin) & Palm Tocotrienol Complex (Tocomin) at FIC 2012, Shanghai
Carotech will share latest scientific developments and application strategies of its Tocomin and Caromin series of ingredients - March 24, 2012 - Carotech Inc.
Office of Naval Research Continues Funding for Innovative Research in Unmanned Naval Vessels
ACCeSS collaborators push the boundaries of naval technology and education. - March 23, 2012 - Stevens Institute of Technology
AnaSpec Develops AMC Resins for SPPS
Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase... - March 22, 2012 - AnaSpec, EGT Group
ALS Therapy Development Institute Announces Eighth Annual "The Cure Is Coming" 5k and Awareness Walk
Participants walk, ride or race to raise money and awareness to end ALS (Lou Gehrig's disease) - March 21, 2012 - ALS Therapy Development Institute
Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement
ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO
Colorado BioScience Association Commends PhRMA and We Work For Health for Showcasing the Critical Importance of Clinical Trials to Chronic Disease Sufferers in the State
Members of Colorado BioScience Association (CBSA) today joined with colleagues from both the public and private sectors, including Colorado Governor John Hickenlooper, at a State Capitol News Conference to applaud the release of PhRMA's new report: “Research in Your Backyard.” Colorado's biopharmaceutical industry assists sufferers of chronic disease and includes approximately 300 companies employing over 5,410 with average salaries of $93,000. - March 19, 2012 - Colorado BioScience Association
Zouch Dynamics Will Distribute Red Cedar Technology Software in the UK
Zouch Dynamics will work with CAE Value AB to sell HEEDS in Europe. - March 16, 2012 - Red Cedar Technology